|
DCAF16 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
1.86969999482756E-08 |
| Normal-vs-Stage3 |
6.66133814775094E-16 |
| Normal-vs-Stage4 |
2.18713935851156E-14 |
| Stage1-vs-Stage2 |
7.367400E-01 |
| Stage1-vs-Stage3 |
9.134200E-02 |
| Stage1-vs-Stage4 |
3.129500E-02 |
| Stage2-vs-Stage3 |
1.733570E-01 |
| Stage2-vs-Stage4 |
6.078300E-02 |
| Stage3-vs-Stage4 |
4.506000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.22044604925031E-16 |
| Normal-vs-AfricanAmerican |
1.51553999999665E-05 |
| Normal-vs-Asian |
6.12110029329926E-10 |
| Caucasian-vs-AfricanAmerican |
3.416600E-01 |
| Caucasian-vs-Asian |
2.861800E-01 |
| AfricanAmerican-vs-Asian |
8.737000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.80966353013901E-14 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
6.146600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62525548574877E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.6304735339645E-12 |
| Normal-vs-Age(81-100Yrs) |
6.325000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.137800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.005600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.304200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.789800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.106600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.173600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.858800E-03 |
| Classical-VS-Follicular |
4.530200E-01 |
| Classical-VS-Other |
7.230600E-01 |
| Classical-VS-Normal |
4.39670522212054E-11 |
| Tall-VS-Follicular |
4.884000E-02 |
| Tall-VS-Other |
5.154200E-01 |
| Tall-VS-Normal |
2.71227484915926E-13 |
| Follicular-VS-Other |
9.562600E-01 |
| Follicular-VS-Normal |
2.16630047233934E-11 |
| Other-VS-Normal |
2.562200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.33066907387547E-15 |
| Normal-vs-N1 |
3.51496609596325E-13 |
| N0-vs-N1 |
1.131760E-01 |
|
|
